Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli
Open Access
- 1 January 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (1) , 155-157
- https://doi.org/10.1128/aac.29.1.155
Abstract
The in vitro activity of Ro 17-2301 was determined and compared with those of aztreonam, ceftazidime, amikacin, and piperacillin against 141 cefotaxime-resistant gram-negative bacilli. Ro 17-2301 was bactericidal, and its activity against the majority of these organisms was equal or superior to those of ceftazidime, aztreonam, and piperacillin. An inoculum effect of Ro 17-2301 and aztreonam for many Pseudomonas aeruginosa and Enterobacter spp. isolates was demonstrated.This publication has 8 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactamAntimicrobial Agents and Chemotherapy, 1985
- In vitro activities of Ro 17-2301 and aztreonam compared with those of other new beta-lactam antibiotics against clinical isolates of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1985
- The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1985
- Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteriaAntimicrobial Agents and Chemotherapy, 1982
- SQ 26,776, a novel -lactam: an in-vitro comparison with other antimicrobial agentsJournal of Antimicrobial Chemotherapy, 1981
- SQ 26,776: in-vitro antibacterial activity and susceptibility to -lactamasesJournal of Antimicrobial Chemotherapy, 1981
- Monobactams--monocyclic -lactam antibiotics produced by bacteriaJournal of Antimicrobial Chemotherapy, 1981